Carregant...
Oncolytic Gene Therapy with Recombinant Vaccinia Strain GLV-2b372 Efficiently Kills Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) commonly presents at a late stage when surgery is no longer a curative option. As such, novel therapies for advanced HCC are needed. Oncolytic viruses are a viable option for cancer therapy due to their ability to specifically infect, replicate within, and...
Guardat en:
| Publicat a: | Surgery |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4819004/ https://ncbi.nlm.nih.gov/pubmed/26049609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2015.03.044 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|